These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 4919554

  • 1. Treatment of menorrhagia with tranexamic acid. A double-blind trial.
    Callender ST, Warner GT, Cope E.
    Br Med J; 1970 Oct 24; 4(5729):214-6. PubMed ID: 4919554
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
    Ylikorkala O, Viinikka L.
    Br J Obstet Gynaecol; 1983 Jan 24; 90(1):78-83. PubMed ID: 6336951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.
    Bonnar J, Sheppard BL.
    BMJ; 1996 Sep 07; 313(7057):579-82. PubMed ID: 8806245
    [Abstract] [Full Text] [Related]

  • 8. A double blind study of the effect of tranexamic acid in essential menorrhagia.
    Vermylen J, Verhaegen-Declercq ML, Fierens F, Verstraete M.
    Bull Soc R Belge Gynecol Obstet; 1968 Sep 07; 38(5):385-90. PubMed ID: 4890296
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161).
    Edlund M, Andersson K, Rybo G, Lindoff C, Astedt B, von Schoultz B.
    Br J Obstet Gynaecol; 1995 Nov 07; 102(11):913-7. PubMed ID: 8534629
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double-blind cross-over study.
    Blohmé G.
    Acta Med Scand; 1972 Oct 07; 192(4):293-8. PubMed ID: 4562897
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antifibrinolytics for heavy menstrual bleeding.
    Lethaby A, Farquhar C, Cooke I.
    Cochrane Database Syst Rev; 2000 Oct 07; (4):CD000249. PubMed ID: 11034679
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tranexamic acid therapy for heavy menstrual bleeding.
    Lumsden MA, Wedisinghe L.
    Expert Opin Pharmacother; 2011 Sep 07; 12(13):2089-95. PubMed ID: 21767224
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of hypermenorrhea with tranexamic acid].
    Petersen K, Jelert H, Diernaes E, Detlefsen GU.
    Ugeskr Laeger; 1983 Sep 05; 145(36):2759-60. PubMed ID: 6356545
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding.
    Winkler UH.
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec 01; 99(2):238-43. PubMed ID: 11788179
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.